Compass Therapeutics reported earnings of -$ 0.15 per CMPX share on Nov 9, 2026, beating analysts' expectations by
| Report Date | Nov 9, 2026 |
|---|---|
| Forecasted EPS | -$ 0.13 |
| Earnings Per Share (Surprise) | -$ 0.15 (-$ 0.02) |
| Last Year's EPS | -$ 0.11 |
| EPS YoY Change |
Out of the last 31 earnings reporting periods, Compass Therapeutics beat analysts’ expectations 10 times and fell short of expectations 8 time(s). Compass Therapeutics reported earnings per share of -$ 0.15 in the last report falling to reach an estimated EPS of -$ 0.13 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.13 | -$ 0.15 | -$ 0.08 | |
| Aug 6, 2026 | -$ 0.11 | -$ 0.13 | -$ 0.14 | |
| May 5, 2026 | -$ 0.10 | -$ 0.10 | -$ 0.12 | |
| Mar 5, 2026 | -$ 0.10 | -$ 0.09 | -$ 0.11 | |
| Nov 5, 2025 | -$ 0.14 | -$ 0.08 | -$ 0.08 | |
| Aug 11, 2025 | -$ 0.13 | -$ 0.14 | -$ 0.10 | |
| May 8, 2025 | -$ 0.12 | -$ 0.12 | -$ 0.08 | |
| Feb 27, 2025 | -$ 0.10 | -$ 0.11 | -$ 0.11 | |
| Nov 12, 2024 | -$ 0.11 | -$ 0.08 | -$ 0.08 | |
| Aug 12, 2024 | -$ 0.10 | -$ 0.10 | -$ 0.09 | |
| May 13, 2024 | -$ 0.11 | -$ 0.08 | -$ 0.06 | |
| Mar 21, 2024 | -$ 0.09 | -$ 0.11 | -$ 0.10 | |
| Nov 9, 2023 | -$ 0.11 | -$ 0.08 | -$ 0.12 | |
| Aug 3, 2023 | -$ 0.08 | -$ 0.09 | -$ 0.08 | |
| May 4, 2023 | -$ 0.11 | -$ 0.06 | -$ 0.07 | |
| Mar 15, 2023 | -$ 0.11 | -$ 0.10 | -$ 0.15 | |
| Nov 9, 2022 | -$ 0.11 | -$ 0.12 | -$ 0.10 | |
| Aug 1, 2022 | -$ 0.09 | -$ 0.08 | -$ 1.07 | |
| May 9, 2022 | -$ 0.11 | -$ 0.07 | -$ 0.14 | |
| Mar 21, 2022 | -$ 0.07 | -$ 0.15 | -$ 0.15 |
Compass Therapeutics’s stock was trading at $ 0.7588 on Nov 8, 2026 a day before the last earnings report was released.Following the release of the earnings report, CMPX’s price increased to $ 0.838 on Nov 10, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.15 | $ 0.7588 | $ 0.838 | |
| Aug 6, 2026 | -$ 0.13 | $ 1.89 | $ 2.15 | |
| May 5, 2026 | -$ 0.10 | $ 1.94 | $ 1.87 | |
| Mar 5, 2026 | -$ 0.09 | $ 5.69 | $ 5.51 | |
| Nov 5, 2025 | -$ 0.08 | $ 3.79 | $ 4.00 | |
| Aug 11, 2025 | -$ 0.14 | $ 2.70 | $ 3.17 | |
| May 8, 2025 | -$ 0.12 | $ 1.76 | $ 1.82 | |
| Feb 27, 2025 | -$ 0.11 | $ 2.97 | $ 2.90 | |
| Nov 12, 2024 | -$ 0.08 | $ 1.90 | $ 1.69 | |
| Aug 12, 2024 | -$ 0.10 | $ 1.09 | $ 1.20 | |
| May 13, 2024 | -$ 0.08 | $ 1.60 | $ 1.62 | |
| Mar 21, 2024 | -$ 0.11 | $ 2.12 | $ 2.13 | |
| Nov 9, 2023 | -$ 0.08 | $ 1.72 | $ 1.55 | |
| Aug 3, 2023 | -$ 0.09 | $ 2.62 | $ 2.52 | |
| May 4, 2023 | -$ 0.06 | $ 3.00 | $ 3.31 | |
| Mar 15, 2023 | -$ 0.10 | $ 3.60 | $ 3.42 | |
| Nov 9, 2022 | -$ 0.12 | $ 4.25 | $ 4.08 | |
| Aug 1, 2022 | -$ 0.08 | $ 2.60 | $ 2.63 | |
| May 9, 2022 | -$ 0.07 | $ 1.69 | $ 1.64 | |
| Mar 21, 2022 | -$ 0.15 | $ 1.30 | $ 1.38 |
Compass Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Compass Therapeutics missed analysts’ expectations during the last earnings period by
